Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laetitia Fuhrmann

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Scientific Reports|May 16, 2020
EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast CarcinomaWei-Wei Shen, Ivan Bièche, Laetitia Fuhrmann, et al.
Cancers|January 21, 2022
Assessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast CancerJohn Alexander, Odette Mariani, Celine Meaudre, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 28, 2018
Distinct expression profiles and functions of Kindlins in breast cancerPaula Azorin, Florian Bonin, Ahmad Moukachar, et al.
Breast Cancer Research : BCR|February 19, 2016
LIN7A is a major determinant of cell-polarity defects in breast carcinomasNadège Gruel, Laetitia Fuhrmann, Catalina Lodillinsky, et al.
Oncotarget|September 8, 2016
ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomasGabrielle Deniziaut, Jean Christophe Tille, François-Clément Bidard, et al.
Histopathology|March 15, 2018
High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breastGuillaume Bataillon, Laetitia Fuhrmann, Elodie Girard, et al.
The Journal of Cell Biology|October 28, 2015
ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasionValentina Marchesin, Antonio Castro-Castro, Catalina Lodillinsky, et al.
Genes, Chromosomes & Cancer|February 6, 2023
MDM4 amplification in atypical lipomatous tumors/well-differentiated liposarcoma: Private event or alternative oncogenic mechanism?Nadège Gruel, Sophie El Zein, Dimitri Tzanis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 9, 2017
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breastMarion Lavigne, Emmanuelle Menet, Jean-Christophe Tille, et al.
The American Journal of Surgical Pathology|September 10, 2019
Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the BreastBeth T Harrison, Elizabeth Fowler, Gregor Krings, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Scientific Reports|May 16, 2020
EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast CarcinomaWei-Wei Shen, Ivan Bièche, Laetitia Fuhrmann, et al.
Cancers|January 21, 2022
Assessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast CancerJohn Alexander, Odette Mariani, Celine Meaudre, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 28, 2018
Distinct expression profiles and functions of Kindlins in breast cancerPaula Azorin, Florian Bonin, Ahmad Moukachar, et al.
Breast Cancer Research : BCR|February 19, 2016
LIN7A is a major determinant of cell-polarity defects in breast carcinomasNadège Gruel, Laetitia Fuhrmann, Catalina Lodillinsky, et al.
Oncotarget|September 8, 2016
ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomasGabrielle Deniziaut, Jean Christophe Tille, François-Clément Bidard, et al.
Histopathology|March 15, 2018
High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breastGuillaume Bataillon, Laetitia Fuhrmann, Elodie Girard, et al.
The Journal of Cell Biology|October 28, 2015
ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasionValentina Marchesin, Antonio Castro-Castro, Catalina Lodillinsky, et al.
Genes, Chromosomes & Cancer|February 6, 2023
MDM4 amplification in atypical lipomatous tumors/well-differentiated liposarcoma: Private event or alternative oncogenic mechanism?Nadège Gruel, Sophie El Zein, Dimitri Tzanis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 9, 2017
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breastMarion Lavigne, Emmanuelle Menet, Jean-Christophe Tille, et al.
The American Journal of Surgical Pathology|September 10, 2019
Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the BreastBeth T Harrison, Elizabeth Fowler, Gregor Krings, et al.
Pageof 4